Mad Money

Cramer's lightning round: Teva Pharmaceuticals is 'not good enough' for your portfolio

Key Points
  • It's that time again! "Mad Money" host Jim Cramer rang the lightning round bell, which means he gave his take on callers' favorite stocks at rapid speed.

The market continues on its wild ride with the Dow Jones Industrial Average closing nearly 425 points lower on Tuesday, only to regain 100 points Wednesday, ultimately closing nearly 60 points higher. And that's just the beginning. First quarter earnings season is now in full swing. The street is expecting a record season.

CNBC's Jim Cramer helped callers quell their fears about a few key stocks.

U.S. Steel:

The company posts earnings on Thursday. But Cramer said he wouldn't be a buyer of the steel play. "We like Nucor," he said on "Mad Money" Wednesday.

Ball Corporation:

"I think Ball's a big winner," Cramer said, pointing out that in the can industry, there are not a lot of players.

Teva Pharmaceuticals:

"Not good enough," Cramer said, comparing it with other drug companies. Better to pass, he said.

CME Group:

Cramer said it's an "ideal stock" in the current environment of volatility and is well-run.

Aqua America:

Cramer said in the current hot economy, this is not the stock to buy, despite it also being a well-run company.


The stock is currently cheap. Cramer said yes — for now. "Buy half," he said, "then wait."

Mueller Water Products:

Cramer said he doesn't like the number. "This is not the time to buy," he said.

Disclosure: Cramer's charitable trust owns shares of Nucor.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website?